Genesis Healthcare Inc (NYSE:GEN) COO Sells $14,529.06 in Stock

Genesis Healthcare Inc (NYSE:GEN) COO Paul David Bach sold 12,418 shares of Genesis Healthcare stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $1.17, for a total transaction of $14,529.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Paul David Bach also recently made the following trade(s):

  • On Monday, June 3rd, Paul David Bach sold 8,616 shares of Genesis Healthcare stock. The stock was sold at an average price of $1.16, for a total transaction of $9,994.56.
  • On Monday, May 20th, Paul David Bach sold 11,540 shares of Genesis Healthcare stock. The shares were sold at an average price of $1.20, for a total transaction of $13,848.00.

Shares of GEN traded up $0.04 during mid-day trading on Friday, reaching $1.23. The company had a trading volume of 351,844 shares, compared to its average volume of 260,343. The firm has a market cap of $198.99 million, a PE ratio of -0.79 and a beta of 0.98. Genesis Healthcare Inc has a fifty-two week low of $1.10 and a fifty-two week high of $2.86.

Genesis Healthcare (NYSE:GEN) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.15) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.25) by $0.10. The company had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.17 billion. Equities research analysts anticipate that Genesis Healthcare Inc will post -0.72 EPS for the current year.

Several institutional investors and hedge funds have recently made changes to their positions in the business. Renaissance Technologies LLC boosted its holdings in shares of Genesis Healthcare by 10.3% in the 1st quarter. Renaissance Technologies LLC now owns 3,366,411 shares of the company’s stock valued at $4,848,000 after purchasing an additional 313,000 shares during the last quarter. BlackRock Inc. boosted its holdings in shares of Genesis Healthcare by 0.7% in the 4th quarter. BlackRock Inc. now owns 3,250,648 shares of the company’s stock valued at $3,835,000 after purchasing an additional 24,163 shares during the last quarter. Columbia Pacific Advisors LLC boosted its holdings in shares of Genesis Healthcare by 1.0% in the 4th quarter. Columbia Pacific Advisors LLC now owns 3,229,829 shares of the company’s stock valued at $3,811,000 after purchasing an additional 32,374 shares during the last quarter. Vanguard Group Inc boosted its holdings in shares of Genesis Healthcare by 0.5% in the 3rd quarter. Vanguard Group Inc now owns 2,424,601 shares of the company’s stock valued at $3,273,000 after purchasing an additional 12,253 shares during the last quarter. Finally, Acadian Asset Management LLC boosted its holdings in shares of Genesis Healthcare by 16.3% in the 1st quarter. Acadian Asset Management LLC now owns 1,968,302 shares of the company’s stock valued at $2,834,000 after purchasing an additional 276,436 shares during the last quarter. Institutional investors own 21.34% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was published by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://transcriptdaily.com/2019/06/15/genesis-healthcare-inc-nysegen-coo-sells-14529-06-in-stock.html.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

Featured Story: What is the significance of a dead cat bounce?

Insider Buying and Selling by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.